当前位置: X-MOL 学术Blood › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
IFN-I promotes T cell-independent immunity and RBC autoantibodies via modulation of B-1 cell subsets in murine SCD.
Blood ( IF 21.0 ) Pub Date : 2024-12-10 , DOI: 10.1182/blood.2024025175
Shan Su,Weili Bao,Yunfeng Liu,Patricia A Shi,Deepa Manwani,Irina Murakhovskaya,Sally Campbell Lee,Cheryl A Lobo,Avital Mendelson,Xiuli An,Hui Zhong,Woelsung Yi,Karina Yazdanbakhsh

The pathophysiology of sickle cell disease (SCD) is characterized by hemolytic anemia and vaso-occlusion, although its impact on the adaptive immune responses remains incompletely understood. To comprehensibly profile the humoral immune responses, we immunized SCD mice with T cell-independent (TI) and T cell-dependent (TD) antigens. Our study showed that SCD mice have significantly enhanced type 2 TI (TI-2) immune responses in a manner dependent on the level of type I IFN (IFN-I), while maintaining similar or decreased TD immune responses depending on the route of antigen administration. Consistent with the enhanced TI-2 immune responses in SCD mice, the frequencies of B-1b cells (B-1 cells in humans), a major cell type responding to TI-2 antigens, were significantly increased in both the peritoneal cavity and spleens of SCD mice and in blood of patients with SCD. In support of expanded B-1 cells, elevated levels of anti-red blood cell (RBC) autoantibodies were detected in both SCD mice and patients. Both the levels of TI-2 immune responses and anti-RBC autoantibodies were significantly reduced following IFNAR antibody blockades and in IFNAR-1 deficient SCD mice. Moreover, the alteration of B-1 cell subsets were reversed in IFNAR-1 deficient SCD mice, uncovering a critical role for IFN-I in the enhanced TI-2 immune responses and the increased production of anti-RBC autoantibodies by modulating the innate B-1 cell subsets in SCD. Overall, our study provides experimental evidence that the modulation of B-1 cells and IFN-I can regulate TI immune responses and the levels of anti-RBC autoantibodies in SCD.

中文翻译:


IFN-I 通过调节小鼠 SCD 中的 B-1 细胞亚群来促进 T 细胞非依赖性免疫和 RBC 自身抗体。



镰状细胞病 (SCD) 的病理生理学特征是溶血性贫血和血管闭塞,但其对适应性免疫反应的影响仍不完全清楚。为了更清楚地了解体液免疫反应,我们用 T 细胞非依赖性 (TI) 和 T 细胞依赖性 (TD) 抗原对 SCD 小鼠进行了免疫接种。我们的研究表明,SCD 小鼠以取决于 I 型 IFN (IFN-I) 水平的方式显着增强 2 型 TI (TI-2) 免疫反应,同时根据抗原给药途径保持相似或降低的 TD 免疫反应。与 SCD 小鼠增强的 TI-2 免疫反应一致,B-1b 细胞(人类 B-1 细胞)的频率(一种响应 TI-2 抗原的主要细胞类型)在 SCD 小鼠的腹膜腔和脾脏以及 SCD 患者的血液中均显著增加。为了支持扩增的 B-1 细胞,在 SCD 小鼠和患者中检测到抗红细胞 (RBC) 自身抗体水平升高。IFNAR 抗体阻断后和 IFNAR-1 缺陷型 SCD 小鼠的 TI-2 免疫反应和抗 RBC 自身抗体水平均显著降低。此外,在 IFNAR-1 缺陷型 SCD 小鼠中,B-1 细胞亚群的改变被逆转,揭示了 IFN-I 通过调节 SCD 中的先天性 B-1 细胞亚群,在增强 TI-2 免疫反应和增加抗 RBC 自身抗体产生中的关键作用。总体而言,我们的研究提供了实验证据,表明 B-1 细胞和 IFN-I 的调节可以调节 TI 免疫反应和 SCD 中抗 RBC 自身抗体的水平。
更新日期:2024-12-10
down
wechat
bug